Publicado 6 números por año
ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502
Indexed in
Chemokines and Chemokine Receptors as Promoters of Prostate Cancer Growth and Progression
SINOPSIS
Prostate cancer (CaP) is estimated to be first in incidence among cancers, with more than 240,000 new cases in 2012 in the United States. Chemokines and their receptors provide survival, proliferation, and invasion characteristics to CaP cells in both primary sites of cancer and metastatic locations. The emerging data demonstrate that many chemokines and their receptors are involved in the multistep process of CaP, leading to metastasis, and, further, that these factors act cooperatively to enhance other mechanisms of tumor cell survival, growth, and metastasis. Changes of chemokine receptor cohorts may be necessary to activate tumor-promoting signals. Chemokine receptors can activate downstream effectors, such as mitogen-activated protein kinases, by complex mechanisms of ligand-dependent activation of cryptic growth factors; guanosine triphosphate−binding, protein-coupled activation of survival kinases; or transactivation of other receptors such as ErbB family members. We describe vanguard research in which more than the classic view of chemokine receptor biology was clarified. Control of chemokines and inhibition of their receptor activation may add critical tools to reduce tumor growth, especially in chemo-hormonal refractory CaP that is both currently incurable and the most aggressive form of the disease, accounting for most of the more than 28,000 annual deaths.
-
Chen Guo, Liang Yu-xiang, Zhu Jian-guo, Fu Xin, Chen Yan-fei, Mo Ru-jun, Zhou Liang, Fu Hao, Bi Xue-cheng, He Hui-chan, Yang Sheng-bang, Wu Yong-ding, Jiang Fu-neng, Zhong Wei-de, CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer, BioMed Research International, 2014, 2014. Crossref
-
Ganguly Sourik S., Li Xiaohong, Miranti Cindy K., The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis, Frontiers in Oncology, 4, 2014. Crossref
-
Hillerdal Victoria, Essand Magnus, Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer, BioDrugs, 29, 2, 2015. Crossref
-
Hu Yong-hua, Zhang Jian, CsCCL17, a CC chemokine of Cynoglossus semilaevis, induces leukocyte trafficking and promotes immune defense against viral infection, Fish & Shellfish Immunology, 45, 2, 2015. Crossref
-
Thapa Dinesh, Ghosh Rita, Chronic inflammatory mediators enhance prostate cancer development and progression, Biochemical Pharmacology, 94, 2, 2015. Crossref
-
Taverna Gianluigi, Pedretti Elisa, Di Caro Giuseppe, Borroni Elena Monica, Marchesi Federica, Grizzi Fabio, Inflammation and prostate cancer: friends or foe?, Inflammation Research, 64, 5, 2015. Crossref
-
Wang Lei-Ping, Cao Jun, Zhang Jian, Wang Bi-Yun, Hu Xi-Chun, Shao Zhi-Min, Wang Zhong-Hua, Ou Zhou-Luo, The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells, Medical Oncology, 32, 11, 2015. Crossref
-
Mo Miao, Zhou Mi, Wang Lu, Qi Lin, Zhou Kehua, Liu Long-Fei, Chen Zhi, Zu Xiong-Bing, Mohanraj Rajesh, CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells, PLOS ONE, 10, 3, 2015. Crossref
-
Karan Dev, Dubey Seema, From Inflammation to Prostate Cancer: The Role of Inflammasomes, Advances in Urology, 2016, 2016. Crossref
-
R.S. Reshma, K.H. Sreelatha, Somasundaram Veena, S. Satheesh Kumar, Nadhan Revathy, Nair Rakesh Sathish, Srinivas Priya, Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells, Pharmacological Research, 105, 2016. Crossref
-
Sciarra Alessandro, Gentilucci Alessandro, Salciccia Stefano, Pierella Federico, Del Bianco Flavio, Gentile Vincenzo, Silvestri Ida, Cattarino Susanna, Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review, Journal of Inflammation, 13, 1, 2016. Crossref
-
Laurent Victor, Guérard Adrien, Mazerolles Catherine, Le Gonidec Sophie, Toulet Aurélie, Nieto Laurence, Zaidi Falek, Majed Bilal, Garandeau David, Socrier Youri, Golzio Muriel, Cadoudal Thomas, Chaoui Karima, Dray Cedric, Monsarrat Bernard, Schiltz Odile, Wang Yuan Yuan, Couderc Bettina, Valet Philippe, Malavaud Bernard, Muller Catherine, Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity, Nature Communications, 7, 1, 2016. Crossref
-
Strömvall Kerstin, Thysell Elin, Halin Bergström Sofia, Bergh Anders, Najbauer Joseph, Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis, PLOS ONE, 12, 5, 2017. Crossref
-
Wang Liang, Zhang Changhua, Xu Jianbo, Wu Hui, Peng Jianjun, Cai Shirong, He Yulong, CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer, Molecular Medicine Reports, 14, 5, 2016. Crossref
-
Dushyanthen Sathana, Cossigny Davina A.F., Quan Gerald M.Y., The Osteoblastic and Osteoclastic Interactions in Spinal Metastases Secondary to Prostate Cancer, Cancer Growth and Metastasis, 6, 2013. Crossref
-
Jin Ya-bin, Zhang Guo-yi, Lin Kai-Rong, Chen Xiang-ping, Cui Jin-Huan, Wang Yue-jian, Luo Wei, Sung Shian-Ying, Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT), PLOS ONE, 12, 2, 2017. Crossref
-
Zhao Yu, The mysterious relation between inflammation and prostate cancer, Infection International, 6, 1, 2017. Crossref
-
Yang Chenggang, Zheng Wanlei, Du Wenfeng, CXCR3A contributes to the invasion and metastasis of gastric cancer cells, Oncology Reports, 36, 3, 2016. Crossref
-
Tsai Chin-Hsien, Tzeng Sheue-Fen, Hsieh Shih-Chuan, Yang Yu-Chih, Hsiao Yi-Wen, Tsai Mong-Hsun, Hsiao Pei-Wen, A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer, Scientific Reports, 7, 1, 2017. Crossref
-
Hoy James J., Kallifatidis Georgios, Smith Diandra K., Lokeshwar Bal L., Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival, Scientific Reports, 7, 1, 2017. Crossref
-
Yildirim Gazi, Attar Rukset, Gulec-Yilmaz Seda, Duman Selvi, Isbir Turgay, Association of CCR2 (+190 G/A) Gene Variants and Ovarian Cancer Severity, Genetic Testing and Molecular Biomarkers, 21, 8, 2017. Crossref
-
Kumar Sanjay, Singh Rajesh, Malik Shalie, Manne Upender, Mishra Manoj, Prostate cancer health disparities: An immuno-biological perspective, Cancer Letters, 414, 2018. Crossref
-
SUN JING, FENG CHEN, LIAO WEIWEI, ZHANG HAO, TANG SUOQIN, Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy, Oncology Letters, 7, 6, 2014. Crossref
-
Caggia Silvia, Chunduri HimaBindu, Millena Ana C., Perkins Jonathan N., Venugopal Smrruthi V., Vo BaoHan T., Li Chunliang, Tu Yaping, Khan Shafiq A., Novel role of Giα2 in cell migration: Downstream of PI3‐kinase–AKT and Rac1 in prostate cancer cells, Journal of Cellular Physiology, 234, 1, 2019. Crossref
-
Ferrer Valéria Pereira, Moura Neto Vivaldo, Mentlein Rolf, Glioma infiltration and extracellular matrix: key players and modulators, Glia, 66, 8, 2018. Crossref
-
Sun Baiming, Lei Yang, Cao Zhenjie, Zhou Yongcan, Sun Yun, Wu Ying, Wang Shifeng, Guo Weiliang, Liu Chunsheng, TroCCL4, a CC chemokine of Trachinotus ovatus, is involved in the antimicrobial immune response, Fish & Shellfish Immunology, 86, 2019. Crossref
-
Mancini Andrea, Colapietro Alessandro, Pompili Simona, Del Fattore Andrea, Delle Monache Simona, Biordi Leda Assunta, Angelucci Adriano, Mattei Vincenzo, Liang Chris, Gravina Giovanni Luca, Festuccia Claudio, Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling, Tumor Biology, 40, 4, 2018. Crossref
-
Rani Aradhana, Dasgupta Prokar, Murphy John J., Prostate Cancer, The American Journal of Pathology, 189, 11, 2019. Crossref
-
Gong Daoyuan, Wang Yunuo, Wang Yong, Chen Xin, Chen ShenYuan, Wang Ruixue, Liu Lian, Duan Chaohui, Luo Shuhong, Extensive serum cytokine analysis in patients with prostate cancer, Cytokine, 125, 2020. Crossref
-
Mir Hina, Singh Rajesh, Kloecker Goetz H., Lillard James W., Singh Shailesh, CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases, Oncotarget, 6, 12, 2015. Crossref
-
Vaidya Foram U., Chhipa Abu Sufiyan, Sagar Nibha, Pathak Chandramani, Oxidative Stress and Inflammation Can Fuel Cancer, in Role of Oxidative Stress in Pathophysiology of Diseases, 2020. Crossref
-
Nagaya Naoya, Lee Geun Taek, Horie Shigeo, Kim Isaac Yi, CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer, Frontiers in Molecular Biosciences, 7, 2020. Crossref
-
Salem Anwar, Alotaibi Mashael, Mroueh Rima, Basheer Haneen A., Afarinkia Kamyar, CCR7 as a therapeutic target in Cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1875, 1, 2021. Crossref
-
He Dan, Zhang Suolin, UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway, Molecular Medicine Reports, 2017. Crossref
-
Nakamura Noriko, Vijay Vikrant, Sloper Daniel T., Gene expression profiling in dorsolateral prostates of prepubertal and adult Sprague-Dawley rats dosed with estradiol benzoate, estradiol, and testosterone, The Journal of Toxicological Sciences, 45, 8, 2020. Crossref
-
Liu Peng , Liang Yun , Jiang Libo , Wang Houlei , Wang Shengxing , Dong Jian , CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway, International Journal of Oncology, 2018. Crossref
-
El-Far Mohamed, Superiority of CCL11x IL-6 over PSA in Prostate Cancer Prediction and Detection in Egyptian Patients: First Preliminary Comparative Assessment, Journal of Cancer Prevention & Current Research, 2, 4, 2015. Crossref
-
Yang Song, Wang Han, Qin Chundi, Sun Hongmei, Han Yupeng, Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer, Bioscience Reports, 40, 8, 2020. Crossref
-
Guérard Adrien, Laurent Victor, Fromont Gaëlle, Estève David, Gilhodes Julia, Bonnelye Edith, Le Gonidec Sophie, Valet Philippe, Malavaud Bernard, Reina Nicolas, Attané Camille, Muller Catherine, The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes, International Journal of Molecular Sciences, 22, 4, 2021. Crossref
-
Zhu Xuewei, Liu Li, Wang Yang, Cong Jianan, Lin Zhang, Wang Yongsen, Liu Qi, Wang Leiming, Yang Ben, Li Tao, lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma, Frontiers in Oncology, 11, 2021. Crossref
-
Huang Renlun, Guo Lang, Gao Menghan, Li Jing, Xiang Songtao, Research Trends and Regulation of CCL5 in Prostate Cancer, OncoTargets and Therapy, Volume 14, 2021. Crossref
-
Li Pupu, Chen Xinfeng, Qin Guohui, Yue Dongli, Zhang Zhen, Ping Yu, Wang Dan, Zhao Xuan, Song Mengjia, Zhao Qitai, Li Jieyao, Liu Shasha, Wang Dong, Zhang Chaoqi, Lian Jingyao, Cao Ling, Li Feng, Huang Lan, Wang Liping, Yang Li, Huang Jianmin, Li Hong, Zhang Bin, Zhang Yi, Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway, Cancer Immunology Research, 6, 10, 2018. Crossref
-
Hu Yangyang, Lu Lin, Xia Yang, Chen Xin, Chang Alfred E., Hollingsworth Robert E., Hurt Elaine, Owen John, Moyer Jeffrey S., Prince Mark E.P., Dai Fu, Bao Yangyi, Wang Yi, Whitfield Joel, Xia Jian-Chuan, Huang Shiang, Wicha Max S., Li Qiao, Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting, Cancer Research, 76, 16, 2016. Crossref
-
Zhu Lizhen, Wang Chengju, Jiang Hongyun, Zhang Lan, Mao Liangang, Zhang Yanning, Qi Suzhen, Liu Xingang, Quizalofop-P-ethyl induced developmental toxicity and cardiotoxicity in early life stage of zebrafish (Danio rerio), Ecotoxicology and Environmental Safety, 238, 2022. Crossref
-
Kallifatidis Georgios, Munoz Daniel, Singh Rajendra Kumar, Salazar Nicole, Hoy James J., Lokeshwar Bal L., β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation, Molecular Cancer Research, 14, 5, 2016. Crossref
-
Joo Mina, Heo Jong, Kim Solbi, Kim Nayoung, Jeon Heung, An Yueun, Song Gyu-Yong, Kim Jin-Man, Lee Hyo, Decursin inhibits tumor progression in head and neck squamous cell carcinoma by downregulating CXCR7 expression in vitro, Oncology Reports, 47, 2, 2021. Crossref
-
Chen Ke, Wu Kongming, Jiao Xuanmao, Wang Liping, Ju Xiaoming, Wang Min, Di Sante Gabriele, Xu Shaohua, Wang Qiong, Li Kevin, Sun Xin, Xu Congwen, Li Zhiping, Casimiro Mathew C., Ertel Adam, Addya Sankar, McCue Peter A., Lisanti Michael P., Wang Chenguang, Davis Richard J., Mardon Graeme, Pestell Richard G., The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module, Cancer Research, 75, 10, 2015. Crossref
-
Mughees Mohd, Kaushal Jyoti Bala, Sharma Gunjan, Wajid Saima, Batra Surinder Kumar, Siddiqui Jawed Akhtar, Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis, Seminars in Cancer Biology, 2022. Crossref
-
Samadi Abbas K., Bilsland Alan, Georgakilas Alexandros G., Amedei Amedeo, Amin Amr, Bishayee Anupam, Azmi Asfar S., Lokeshwar Bal L., Grue Brendan, Panis Carolina, Boosani Chandra S., Poudyal Deepak, Stafforini Diana M., Bhakta Dipita, Niccolai Elena, Guha Gunjan, Vasantha Rupasinghe H.P., Fujii Hiromasa, Honoki Kanya, Mehta Kapil, Aquilano Katia, Lowe Leroy, Hofseth Lorne J., Ricciardiello Luigi, Ciriolo Maria Rosa, Singh Neetu, Whelan Richard L., Chaturvedi Rupesh, Ashraf S. Salman, Shantha Kumara H.M.C., Nowsheen Somaira, Mohammed Sulma I., Keith W. Nicol, Helferich William G., Yang Xujuan, A multi-targeted approach to suppress tumor-promoting inflammation, Seminars in Cancer Biology, 35, 2015. Crossref
-
Karpova Yaroslava, Johnson Sarah J., Bordet Guillaume, Guo Danping, Ghatak Atreyi, Markov Dmitriy A., Tulin Alexei V., Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes, Biomedicine & Pharmacotherapy, 153, 2022. Crossref
-
Chen Lei, Zheng Yi, Jiang Changqin, Yang Cheng, Zhang Li, Liang Chaozhao, The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies, Frontiers in Immunology, 13, 2022. Crossref